Evidence map›Paper›PMID 20447867›Full record

ReviewCurrent opinion in pharmacology2010

Emerging strategies to boost thymic function.

Georg A Holländer, Werner Krenger, Bruce R Blazar

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Thymus Degeneration and Regeneration.Frontiers in immunology · 2021
    Review
  9. Review
  10. Review
  11. T cell receptor excision circles as a tool for evaluating thymic function in young children.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  16. Review
  17. Article
  18. Interleukin-22: immunobiology and pathology.Annual review of immunology · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Georg A HolländerLaboratory of Pediatric Immunology, Department of Biomedicine, University of Basel, The University Children's Hospital (UKBB), Mattenstrasse 28, 4058 Basel, Switzerland. georga.hollaender@unibas.ch
Werner Krenger
Bruce R Blazar
University of Basel · CHUniversity of Minnesota · US

Funding

Trial Design and Biostatistical Support CoreP01CA065493 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1995 to 2026
$48.2M
Molecular Mechanisms of Thymic Epithelial Cell Involution in AgingR01AG034874 · NIA · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2009 to 2013
$1.6M
INVASIVE GLIOMA CELLSF32CA067493 · NCI · WASHINGTON UNIVERSITY · PI CHICOINE, MICHAEL R · 1995 to 1996
–
NCI NIH HHS F32 CA067493NCI NIH HHS P01 CA065493NCI NIH HHS P01CA067493NIAID NIH HHS R01-AI081918NIA NIH HHS R01 AG034874
6 · The paper itself

Abstract

The thymus constitutes the primary lymphoid organ for the generation of T cells. Its function is particularly susceptible to various negative influences ranging from age-related involution to atrophy as a consequence of malnutrition, infection or harmful iatrogenic influences such as chemotherapy and radiation. The loss of regular thymus function significantly increases the risk for infections and cancer because of a restricted capacity for immune surveillance. In recent years, thymus-stimulatory, thymus-regenerative, and thymus-protective strategies have been developed to enhance and repair thymus function in the elderly and in individuals undergoing hematopoietic stem cell transplantation. These strategies include the use of sex steroid ablation, the administration of growth and differentiation factors, the inhibition of p53, and the transfer of T cell progenitors to alleviate the effects of thymus dysfunction and consequent T cell deficiency.

Indexed as

AgingAndrogen AntagonistsAnimalsAntineoplastic AgentsAtrophyGraft vs Host DiseaseGrowth HormoneHumansInfectionsMalnutritionRadiotherapySomatomedinsThymus GlandT-LymphocytesAndrogen AntagonistsAntineoplastic AgentsGrowth HormoneSomatomedins

Identifiers

PMID20447867
PMCPMC3123661
OpenAlexW2162144888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.